345 related articles for article (PubMed ID: 1991829)
21. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.
Hogan M; Cerami A; Bucala R
J Clin Invest; 1992 Sep; 90(3):1110-5. PubMed ID: 1522220
[TBL] [Abstract][Full Text] [Related]
22. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.
Vlassara H; Fuh H; Makita Z; Krungkrai S; Cerami A; Bucala R
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12043-7. PubMed ID: 1465438
[TBL] [Abstract][Full Text] [Related]
23. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy.
Eaton JW; Qian M
Mol Cell Biochem; 2002; 234-235(1-2):135-42. PubMed ID: 12162426
[TBL] [Abstract][Full Text] [Related]
24. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.
Brownlee M; Vlassara H; Kooney A; Ulrich P; Cerami A
Science; 1986 Jun; 232(4758):1629-32. PubMed ID: 3487117
[TBL] [Abstract][Full Text] [Related]
25. Proteins lose their nitric oxide stabilizing function after advanced glycosylation.
Farkas J; Menzel EJ
Biochim Biophys Acta; 1995 Dec; 1245(3):305-10. PubMed ID: 8541305
[TBL] [Abstract][Full Text] [Related]
26. Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibition.
Bucala R; Vlassara H
Blood Purif; 1995; 13(3-4):160-70. PubMed ID: 7619388
[TBL] [Abstract][Full Text] [Related]
27. Glycosylation products as toxic mediators of diabetic complications.
Brownlee M
Annu Rev Med; 1991; 42():159-66. PubMed ID: 2035962
[TBL] [Abstract][Full Text] [Related]
28. [Nitric oxide in endothelium-dependent vasodilatation. Bases of the unity of the endothelium and smooth muscle cells in paracrine metabolic regulation].
Titov VN
Klin Lab Diagn; 2007 Feb; (2):23-4, 33-9. PubMed ID: 17436699
[No Abstract] [Full Text] [Related]
29. What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?
Bucala R
Diabetes Res Clin Pract; 1996 Feb; 30 Suppl():123-30. PubMed ID: 8964186
[TBL] [Abstract][Full Text] [Related]
30. Diabetes-induced decreased sensitivity to blocking drugs of autonomic ganglia and motor endplates: new hypothesis for an old observation.
Koltai M
Acta Physiol Hung; 1991; 77(3-4):217-23. PubMed ID: 1755326
[No Abstract] [Full Text] [Related]
31. Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues.
Vlassara H
Diabetes; 1992 Oct; 41 Suppl 2():52-6. PubMed ID: 1326453
[TBL] [Abstract][Full Text] [Related]
32. Hemoglobin-AGE: a circulating marker of advanced glycosylation.
Makita Z; Vlassara H; Rayfield E; Cartwright K; Friedman E; Rodby R; Cerami A; Bucala R
Science; 1992 Oct; 258(5082):651-3. PubMed ID: 1411574
[TBL] [Abstract][Full Text] [Related]
33. Biological effects of aminoguanidine: an update.
Nilsson BO
Inflamm Res; 1999 Oct; 48(10):509-15. PubMed ID: 10563466
[TBL] [Abstract][Full Text] [Related]
34. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.
Moncada S; Radomski MW; Palmer RM
Biochem Pharmacol; 1988 Jul; 37(13):2495-501. PubMed ID: 3291879
[No Abstract] [Full Text] [Related]
35. Carbohydrate regulated transendothelial transport of proteins.
Williams SK; Rose DG
Adv Exp Med Biol; 1988; 242():179-83. PubMed ID: 3245510
[No Abstract] [Full Text] [Related]
36. Hydroxocobalamins as biologically compatible donors of nitric oxide implicated in the acceleration of wound healing.
Bauer JA
Med Hypotheses; 1998 Jul; 51(1):65-7. PubMed ID: 9881839
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of nitric oxide formation and prevention of type 1 diabetes.
Papaccio G
Autoimmunity; 1995; 20(1):69, 71. PubMed ID: 7578864
[No Abstract] [Full Text] [Related]
38. Nitric Oxide and Cardiovascular Regulation: Beyond the Endothelium.
Fadel PJ
Hypertension; 2017 May; 69(5):778-779. PubMed ID: 28264921
[No Abstract] [Full Text] [Related]
39. Probing shear-stress-mediated cerebral vasodilatation in humans - it's a NO brainer.
Fan JL; Fisher JP
J Physiol; 2022 Mar; 600(6):1283-1284. PubMed ID: 35001389
[No Abstract] [Full Text] [Related]
40. Chronic diabetic complications and tissue glycosylation. Relevant concern for diabetes-prone black population.
Vlassara H
Diabetes Care; 1990 Nov; 13(11):1180-5. PubMed ID: 2261839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
